中文     English

OPL Cares about Human Health

The World Benefits from OPL’s Technology

About Us

Specializing in oral solid sustained-release technology, sustained-release new drugs, and related fields.
A leading Controlled Release DDS company with a focus to enhance the value of your existing assets (LCM) by offering superior efficacy and safety profiles, convenient to use, extended IP protection, and combination products.
12 years product development effort resulted in rich post-POC pipelines for your fast commercialization.
About 200 Subject-Matter-Experts and Scientists globally to help fulfill your unmet needs.

Core Team Members

Dr.Gilbert

Gilbert Wen, Ph.D

CEO
Founder and Chairman of the Board

Dr.Gilbert Wen-Founder and Chairman of the Board

Dr.Danchen Gao

Danchen Gao, Ph.D

Chief Strategy Officer

Dr. Danchen Gao-Chief Strategy Officer

Dr.Zhi Liu

Alex Liu, Ph.D

Head, Innovation Center

Dr. Alex Liu-Head, Innovation Center

Dr. Bruce Cai

Bruce Cai, Ph.D

Clinical Director

Dr. Bruce Cai-Clinical Director

Dr.Shuo Zhang

Shuo Zhang, Ph.D

R&D Director

Dr. Shuo Zhang-R&D Director

Maggie Lu M.D

Maggie Lu M.D

Medical Director

Maggie Lu M.D Lu-Wedical Director

闻晓光博士

Gilbert Wen, Ph.D

CEO
Founder and Chairman of the Board

Dr.Danchen Gao

Danchen Gao, Ph.D

Chief Strategy Officer

Dr.Zhi Liu

Alex Liu, Ph.D

Head, Innovation Center

蔡怀涵博士

Bruce Cai, Ph.D

Clinical Director

张硕博士

Shuo Zhang, Ph.D

R&D Director

吕敏燕医生

Maggie Lu M.D

Medical Director

Product



US FDA Approved Product
Levetiracetam Extended Release Tablet has been approved by US FDA


US FDA Accepted Application for Approval
Lamotrigine Extended Release has been accepted by US FDA for review
NDA batch manufacture
Ibuprofen Bilayer Tablet has been conducted
Approval of clinical trials
12 INDs (Investigational New Drug) have been granted by US FDA for clinical trials
Pilot PK studies
21 human pilot PK studies have been conducted
Animal PK studies
14 animal studies have been conducted for new drug candidates
Development Timeline

About us
Introduction
Core Team
Technology
Product
Product Development Status
Clinical Trials Approval
Development Timeline
Capability
Equipment
Apparatus
Facilities
Collaboration
Visit to Clinical Sites
Collaboration Partners
Copyright Overseas Pharmaceuticals, Ltd. 苏ICP备15022868号-1